# FDA Inspection 1314718 - Samson Pharmaceuticals, Inc - April 29, 2026

Source: https://www.keypedia.com/records/fda_inspections/samson-pharmaceuticals-inc/c5ccd952-6c74-486d-a807-a72f44173f28
Source feed: FDA_Inspections

> FDA Inspection 1314718 for Samson Pharmaceuticals, Inc on April 29, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1314718
- Company Name: Samson Pharmaceuticals, Inc
- Inspection Date: 2026-04-29
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1040504 - 2018-02-09](https://www.keypedia.com/records/fda_inspections/samson-pharmaceuticals-inc/2fcc35f4-af43-4fb7-9992-894610e7c1dc)
- [FDA Inspection 988639 - 2016-03-25](https://www.keypedia.com/records/fda_inspections/samson-pharmaceuticals-inc/6c0645d9-9ed2-4d71-adb9-b3b0340f4d1e)

Company: https://www.keypedia.com/companies/samson-pharmaceuticals-inc/4250f533-840c-44d3-a3e7-cc538c63ca03

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b